Vascular Embolization Market Is Estimated To Witness High Growth Owing To Increased Need For Minimally Invasive Procedures
Vascular embolization is a minimally invasive procedure that involves blocking blood vessels using embolic agents. Embolization can help control internal bleeding, prevent or treat aneurysms, and destroy tumors by cutting off their blood supply. These procedures offer several advantages over traditional open surgeries such as less pain, reduced scarring, shorter hospital stays, and faster recovery times. The growing geriatric population is more prone to conditions such as aneurysms, uterine fibroids, and tumors, thereby increasing the demand for vascular embolization procedures.
The global Vascular Embolization Market is estimated to be valued at Us$ 1809.45 Mn in 2023 and is expected to exhibit a CAGR Of 11% over the forecast period 2023 To 2030, as highlighted in a new report published by Coherent Market Insights.
Market Opportunity: Increased Need for Minimally Invasive Procedures
Vascular embolization provides a minimally invasive alternative to open surgeries for various medical conditions. These procedures cause less pain, scarring, and risk of infection compared to conventional open surgeries. With significant advancements in embolization devices and techniques, an increasing number of complex conditions can now be treated using minimally invasive procedures. Moreover, vascular embolization offers advantages like shorter hospital stays, faster recovery times, and lower healthcare costs. As patients growingly prefer minimally invasive options, the demand for vascular embolization is expected to boost significantly over the forecast period. Wider acceptance and adoption of embolization among healthcare providers and patients is estimated to present lucrative growth opportunities for players in the global vascular embolization market.
Porter's Analysis
Threat of new entrants: Low as significant capital investments are needed along with expertise to develop technologies and products. However, the market growth presents opportunities.
Bargaining power of buyers: Moderate as there are several suppliers for similar products but market differentiation gives suppliers an edge.
Bargaining power of suppliers: Moderate as key materials and components require specialized expertise. However, big players can impact prices.
Threat of new substitutes: Low as there are limited alternatives for such procedures presently. However, there is ongoing R&D for new minimally invasive methods.
Competitive rivalry: High as the major players compete on technology, product quality, service and geographic presence.
SWOT Analysis
Strength: Advanced catheter technologies, adoption of robotics and imaging systems help precise procedures. Growing aging population increases target diseases.
Weakness: High costs of equipment, ongoing training needs and local regulatory challenges. Dependency on reimbursement policies.
Opportunity: Expanding into developing economies, new applications in oncology, trauma and pediatric areas present scope. Increasing collaboration with radiology and interventional radiology.
Threats: Supply chain disruptions and economic slowdowns impact investments. Stringent regulations for new product approvals.
Key Takeaways
The Global Vascular Embolization Market Demand is expected to witness high growth over 2023-2030 on account of rising incidence of target diseases and minimally invasive procedures. The global vascular embolization market is estimated to be valued at US$ 1809.45 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030.
The North American region currently dominates the market followed by Europe owing to advanced healthcare settings, favorable reimbursements and significant research investments in the area.
Key players operating in the vascular embolization market are DyCare, Costaisa, Meditouch, Signo Motus srl, MEYTEC GmbH Informationssysteme, and Raccoon Technologies Poland LLC. Major players are engaged in new product launches, partnerships and geographic expansion to gain shares. However, ongoing emphasis on training, cost management and compliance will be critical for long term growth. Localized device development can further aid market access.
Get more insights on this topic :